Millennium Management LLC grew its holdings in shares of Liquidia Technologies Inc (NASDAQ:LQDA) by 91.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 193,277 shares of the company’s stock after acquiring an additional 92,399 shares during the quarter. Millennium Management LLC owned about 1.25% of Liquidia Technologies worth $4,186,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Geode Capital Management LLC grew its stake in shares of Liquidia Technologies by 50.1% in the fourth quarter. Geode Capital Management LLC now owns 49,319 shares of the company’s stock valued at $1,068,000 after buying an additional 16,453 shares in the last quarter. Northern Trust Corp grew its stake in shares of Liquidia Technologies by 9.5% in the fourth quarter. Northern Trust Corp now owns 56,333 shares of the company’s stock valued at $1,221,000 after buying an additional 4,864 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Liquidia Technologies in the fourth quarter valued at $403,000. BlackRock Inc. grew its stake in shares of Liquidia Technologies by 7.1% in the fourth quarter. BlackRock Inc. now owns 231,400 shares of the company’s stock valued at $5,011,000 after buying an additional 15,415 shares in the last quarter. Finally, New York State Common Retirement Fund bought a new position in shares of Liquidia Technologies in the fourth quarter valued at $96,000. Hedge funds and other institutional investors own 46.84% of the company’s stock.
Several equities analysts recently weighed in on LQDA shares. Wedbush reissued a “buy” rating and issued a $47.00 target price on shares of Liquidia Technologies in a research note on Wednesday, January 16th. Zacks Investment Research raised shares of Liquidia Technologies from a “sell” rating to a “hold” rating in a research report on Friday, January 4th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Liquidia Technologies presently has an average rating of “Buy” and a consensus price target of $37.00.
LQDA stock opened at $9.66 on Wednesday. The company has a quick ratio of 4.85, a current ratio of 4.85 and a debt-to-equity ratio of 0.64. Liquidia Technologies Inc has a one year low of $9.75 and a one year high of $38.46.
Liquidia Technologies (NASDAQ:LQDA) last released its quarterly earnings data on Tuesday, February 26th. The company reported ($0.62) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.70) by $0.08. Sell-side analysts expect that Liquidia Technologies Inc will post -2.14 EPS for the current fiscal year.
Liquidia Technologies Profile
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension.
Further Reading: How to Use the New Google Finance Tool
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.